Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
To cover taxesNo plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 4 of the 13 calendar months from Oct 2025 to Oct 2026: Nov 2025, Dec 2025, Feb 2026 and Mar 2026.
- Largest single sale: $956K (5,250 shares) of Jazz Pharmaceuticals plc on Nov 18, 2025. Filing
- Last sale before this period: Mar 10, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Jazz Pharmaceuticals plc (JAZZ) | SVP, Chief Accounting Officer | Aug 12, 2019 | Mar 9, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Mar 9, 2026, Jazz Pharmaceuticals plc: sold 1,287 shares for $235K, no plan disclosed. 1 filing: 1
- Mar 5, 2026, Jazz Pharmaceuticals plc: 1,436 shares withheld by the company for taxes. 1 filing: 1
- Feb 27, 2026, Jazz Pharmaceuticals plc: sold 1,117 shares for $213K, no plan disclosed. 1 filing: 1
- Feb 26, 2026, Jazz Pharmaceuticals plc: sold 1,253 shares for $243K, to cover taxes; 2,223 shares granted. 1 filing: 1
- Jan 16, 2026, Jazz Pharmaceuticals plc: 2,370 shares awarded. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.